0000904454-16-001302.txt : 20160701 0000904454-16-001302.hdr.sgml : 20160701 20160701180952 ACCESSION NUMBER: 0000904454-16-001302 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160629 FILED AS OF DATE: 20160701 DATE AS OF CHANGE: 20160701 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC CENTRAL INDEX KEY: 0001105533 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562110007 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 BUSINESS PHONE: 9192876300 MAIL ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 FORMER COMPANY: FORMER CONFORMED NAME: MERIX BIOSCIENCE INC DATE OF NAME CHANGE: 20000207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Public Joint Stock Co Pharmstandard CENTRAL INDEX KEY: 0001598754 STATE OF INCORPORATION: 1Z FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35443 FILM NUMBER: 161747798 BUSINESS ADDRESS: STREET 1: LIKHACHEVSKY DRIVE STREET 2: 5 "B" CITY: DOLGOPRUDNY STATE: 1Z ZIP: 141701 BUSINESS PHONE: 7 495 970 0032 MAIL ADDRESS: STREET 1: LIKHACHEVSKY DRIVE STREET 2: 5 "B" CITY: DOLGOPRUDNY STATE: 1Z ZIP: 141701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pharmstandard International S.A. CENTRAL INDEX KEY: 0001598762 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35443 FILM NUMBER: 161747799 BUSINESS ADDRESS: STREET 1: 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE CITY: LUXEMBOURG STATE: N4 ZIP: L-1528 BUSINESS PHONE: 352 26449 557 MAIL ADDRESS: STREET 1: 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE CITY: LUXEMBOURG STATE: N4 ZIP: L-1528 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2016-06-29 0001105533 ARGOS THERAPEUTICS INC ARGS 0001598762 Pharmstandard International S.A. 10A, RUE HENRY SCHNADT LUXEMBOURG N4 L-2530 LUXEMBOURG 0 0 1 0 0001598754 Public Joint Stock Co Pharmstandard LIKHACEVSKY DRIVE 5 "B" DOLGOPRUDNY 1Z 141700 RUSSIAN FEDERATION 0 0 1 0 Common Stock 2016-06-29 4 P 0 2678301 A 10447384 I See footnote Warrant to Purchase Common Stock 5.35 2016-06-29 4 P 0 2008726 A 2016-06-29 2021-06-29 Common Stock 2008726 2008726 I See footnote The reported securities are included within Units purchased by the Reporting Persons for $5.44375 per Unit. Each Unit consists of one share of common stock and one warrant to purchase 0.75 shares of common stock. Pharmstandard International S.A. is a wholly owned subsidiary of Public Joint Stock Company Pharmstandard. As the parent entity, Public Joint Stock Company Pharmstandard has voting power over the shares of the Issuer held by Pharmstandard International S.A. /s/ Lori R. Harrelson, as attorney-in-fact for Pharmstandard International S.A. 2016-07-01 /s/ Lori R. Harrelson, as attorney-in-fact for Public Joint Stock Company Pharmstandard 2016-07-01